Activin and Inhibin

KSI-3716 is a potent c-Myc inhibitor that blocks c-MYC/MAX binding to target gene promoters. KSI-3716 is an effective intravesical chemotherapy agent for bladder cancerIn VitroKSI-3716 blocks c-MYC/MAX from forming a complex with target gene

KSI-3716 is a potent c-Myc inhibitor that blocks c-MYC/MAX binding to target gene promoters. KSI-3716 is an effective intravesical chemotherapy agent for bladder cancerIn VitroKSI-3716 blocks c-MYC/MAX from forming a complex with target gene

KSI-3716 is a potent c-Myc inhibitor that blocks c-MYC/MAX binding to target gene promoters. KSI-3716 is an effective intravesical chemotherapy agent for bladder cancerIn VitroKSI-3716 blocks c-MYC/MAX from forming a complex with target gene

KT182 is a potent and selective inhibitor of α/β-hydrolase domain containing 6 (ABHD6) , with an IC 50 of 0.24 nM in Neuro2A cellsForm:SolidIC50&amp: Target:IC50: 0.24 nM (ABHD6 in Neuro2A cells).

KT182 is a potent and selective inhibitor of α/β-hydrolase domain containing 6 (ABHD6) , with an IC 50 of 0.24 nM in Neuro2A cellsForm:SolidIC50&amp: Target:IC50: 0.24 nM (ABHD6 in Neuro2A cells).

KT182 is a potent and selective inhibitor of α/β-hydrolase domain containing 6 (ABHD6) , with an IC 50 of 0.24 nM in Neuro2A cellsIC50&amp: Target:IC50: 0.24 nM (ABHD6 in Neuro2A cells).

KT185 is an orally-bioavailable, brain-penetrant and selective ABHD6 inhibitor, with an IC 50 0.21 nM in Neuro2A cellsForm:SolidIC50&amp: Target:IC50: ABHD6 (0.21 nM in Neuro2A cells).

KT185 is an orally-bioavailable, brain-penetrant and selective ABHD6 inhibitor, with an IC 50 0.21 nM in Neuro2A cellsForm:SolidIC50&amp: Target:IC50: ABHD6 (0.21 nM in Neuro2A cells).

KT185 is an orally-bioavailable, brain-penetrant and selective ABHD6 inhibitor, with an IC 50 0.21 nM in Neuro2A cellsIC50&amp: Target:IC50: ABHD6 (0.21 nM in Neuro2A cells).

KT203 is a potent and selective inhibitor of α/β-hydrolase domain containing 6 (ABHD6) , with an IC 50 of 0.31 nM in Neuro2A cellsForm:SolidIC50&amp: Target:IC50: 0.31 nM (ABHD6 in Neuro2A cells).

KT203 is a potent and selective inhibitor of α/β-hydrolase domain containing 6 (ABHD6) , with an IC 50 of 0.31 nM in Neuro2A cellsForm:SolidIC50&amp: Target:IC50: 0.31 nM (ABHD6 in Neuro2A cells).

KT203 is a potent and selective inhibitor of α/β-hydrolase domain containing 6 (ABHD6) , with an IC 50 of 0.31 nM in Neuro2A cellsIC50&amp: Target:IC50: 0.31 nM (ABHD6 in Neuro2A cells).